NASDAQ · IZM
ICZOOM Group financials
$1.21−3.97%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Jun 30 | Q4 '24 Jun 30 | Q4 '23 Jun 30 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Gross margin | — | — | — |
| Operating income | — | — | — |
| Net income | — | — | — |
| Net margin | — | — | — |
| Diluted EPS | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — |
| Free cash flow | — | — | — |
| Diluted shares | 11.6M | 11.1M | 9.9M |
Balance sheet
| Period end | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|
| Cash & equivalents | $1.8M | $2.5M | $1.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $14.2M | $11.8M | $14.0M |
| Total assets | $41.2M | $40.0M | $88.2M |
| Total liabilities | $25.8M | $24.6M | $72.6M |
| Shareholders' equity | $15.4M | $15.4M | $15.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology